Gonchar Anastasiia D, Kopylova Galina V, Kochurova Anastasia M, Berg Valentina Y, Shchepkin Daniil V, Koubasova Natalia A, Tsaturyan Andrey K, Kleymenov Sergey Y, Matyushenko Alexander M, Levitsky Dmitrii I
A.N. Bach Institute of Biochemistry, Research Center of Biotechnology, Russian Academy of Sciences, Moscow, 119071, Russia; Department of Biochemistry, School of Biology, Moscow State University, Moscow, 119234, Russia.
Institute of Immunology and Physiology, The Russian Academy of Sciences, Yekaterinburg, 620049, Russia.
Biochem Biophys Res Commun. 2021 Jan 1;534:8-13. doi: 10.1016/j.bbrc.2020.11.103. Epub 2020 Dec 8.
Tropomyosin (Tpm) is an actin-binding protein that plays a crucial role in the regulation of muscle contraction. Numerous point mutations in the TPM3 gene encoding Tpm of slow skeletal muscles (Tpm 3.12 or γ-Tpm) are associated with the genesis of various congenital myopathies. Two of these mutations, R91P and R245G, are associated with congenital fiber-type disproportion (CFTD) characterized by hypotonia and generalized muscle weakness. We applied various methods to investigate how these mutations affect the structural and functional properties of γγ-Tpm homodimers. The results show that both these mutations lead to strong structural changes in the γγ-Tpm molecule and significantly impaired its functional properties. These changes in the Tpm properties caused by R91P and R245G mutations give insight into the molecular mechanism of the CFTD development and the weakness of slow skeletal muscles observed in this inherited disease.
原肌球蛋白(Tpm)是一种肌动蛋白结合蛋白,在肌肉收缩调节中起关键作用。编码慢肌骨骼肌Tpm(Tpm 3.12或γ-Tpm)的TPM3基因中的众多点突变与各种先天性肌病的发生有关。其中两个突变,R91P和R245G,与以肌张力减退和全身肌无力为特征的先天性纤维类型不均衡(CFTD)有关。我们应用了各种方法来研究这些突变如何影响γγ-Tpm同二聚体的结构和功能特性。结果表明,这两个突变都导致γγ-Tpm分子发生强烈的结构变化,并显著损害其功能特性。由R91P和R245G突变引起的Tpm特性变化,有助于深入了解CFTD的发病分子机制以及在这种遗传性疾病中观察到的慢肌骨骼肌无力现象。